Thompson Siegel & Walmsley LLC decreased its stake in Koninklijke Philips (NYSE:PHG – Free Report) by 13.2% during the 3rd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,679,033 shares of the technology company’s stock after selling 254,986 shares during the period. Thompson Siegel & Walmsley LLC owned 0.18% of Koninklijke Philips worth $54,938,000 as of its most recent filing with the SEC.
Other hedge funds also recently modified their holdings of the company. Creative Planning increased its position in Koninklijke Philips by 39.3% in the third quarter. Creative Planning now owns 84,263 shares of the technology company’s stock worth $2,757,000 after buying an additional 23,768 shares during the last quarter. Envestnet Portfolio Solutions Inc. increased its stake in shares of Koninklijke Philips by 12.9% in the second quarter. Envestnet Portfolio Solutions Inc. now owns 26,515 shares of the technology company’s stock worth $668,000 after purchasing an additional 3,040 shares in the last quarter. International Assets Investment Management LLC bought a new stake in shares of Koninklijke Philips in the third quarter valued at approximately $1,360,000. Sanctuary Advisors LLC purchased a new stake in shares of Koninklijke Philips during the 2nd quarter valued at approximately $1,253,000. Finally, Sequoia Financial Advisors LLC bought a new stake in Koninklijke Philips during the 2nd quarter valued at $217,000. Institutional investors own 13.67% of the company’s stock.
Koninklijke Philips Stock Performance
Shares of NYSE PHG opened at $26.31 on Thursday. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.16 and a quick ratio of 0.74. The business has a 50-day moving average of $29.81 and a 200-day moving average of $28.27. Koninklijke Philips has a 12 month low of $19.49 and a 12 month high of $32.91.
Analyst Ratings Changes
Read Our Latest Analysis on PHG
Koninklijke Philips Company Profile
Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.
See Also
- Five stocks we like better than Koninklijke Philips
- How to Most Effectively Use the MarketBeat Earnings Screener
- Robinhood’s 330% Surge: Sustainable Rally or Bull Market Mirage?
- How to Invest in Blue Chip Stocks
- Why SoundHound AI Could Be the Next AI Powerhouse
- Overbought Stocks Explained: Should You Trade Them?
- Lowe’s Stock Dip: Don’t Miss This Second-Chance Entry Point
Want to see what other hedge funds are holding PHG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Koninklijke Philips (NYSE:PHG – Free Report).
Receive News & Ratings for Koninklijke Philips Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Koninklijke Philips and related companies with MarketBeat.com's FREE daily email newsletter.